Literature DB >> 8542110

Risk factors for nosocomial pneumonia: comparing adult critical-care populations.

K M Cunnion1, D J Weber, W E Broadhead, L C Hanson, C F Pieper, W A Rutala.   

Abstract

The purpose of the study was to examine risk factors for nosocomial pneumonia in the surgical and medical/respiratory intensive care unit (ICU) populations. In a public teaching hospital, all cases of nosocomial pneumonia in the surgical and medical/respiratory ICUs (n = 20, respectively) were identified by prospective surveillance during a 5-yr period from 1987-1991. Each group of ICU cases was compared with 40 ICU control patients who did not acquire pneumonia, and analyzed for 25 potential risk factors. Surgical ICU patients were found to have consistently higher rates of nosocomial pneumonia than medical ICU patients (RR = 2.2). The strongest predictor for nosocomial pneumonia in both the surgical and medical/respiratory ICU groups was found to be prolonged mechanical ventilation (> 1 d) resulting in a 12-fold increase in risk over nonventilated patients. APACHE III score was found to be predictive of nosocomial pneumonia in the surgical ICU population, but not in the medical/respiratory ICU population. We conclude that certain groups deserve special attention for infection control intervention. Surgical ICU patients with high APACHE scores and receiving prolonged mechanical ventilation may be at the greatest risk of acquiring nosocomial pneumonia of all hospitalized patients.

Entities:  

Mesh:

Year:  1996        PMID: 8542110     DOI: 10.1164/ajrccm.153.1.8542110

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  27 in total

1.  Randomized Pilot Trial of Two Modified Endotracheal Tubes To Prevent Ventilator-associated Pneumonia.

Authors:  Steven Deem; David Yanez; Laura Sissons-Ross; Jo Ann Elrod Broeckel; Stephen Daniel; Miriam Treggiari
Journal:  Ann Am Thorac Soc       Date:  2016-01

2.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  Incidence and risk factors for ventilator-associated pneumonia after major heart surgery.

Authors:  Javier Hortal; Maddalena Giannella; Maria Jesús Pérez; José Maria Barrio; Manuel Desco; Emilio Bouza; Patricia Muñoz
Journal:  Intensive Care Med       Date:  2009-06-26       Impact factor: 17.440

4.  Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey.

Authors:  Hakan Erbay; Ata Nevzat Yalcin; Simay Serin; Huseyin Turgut; Erkan Tomatir; Banu Cetin; Mehmet Zencir
Journal:  Intensive Care Med       Date:  2003-08-01       Impact factor: 17.440

5.  Distribution and antibiotic resistance of pathogens isolated from ventilator-associated pneumonia patients in pediatric intensive care unit.

Authors:  Xiao-Fang Cai; Ji-Min Sun; Lian-Sheng Bao; Wen-Bin Li
Journal:  World J Emerg Med       Date:  2011

Review 6.  Ventilator associated pneumonia.

Authors:  J D Hunter
Journal:  Postgrad Med J       Date:  2006-03       Impact factor: 2.401

7.  Noninvasive ventilation for patients near the end of life: what do we know and what do we need to know?

Authors:  William J Ehlenbach; J Randall Curtis
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

8.  Pre-emptive broad-spectrum treatment for ventilator-associated pneumonia in high-risk patients.

Authors:  Emilio Bouza; María Jesús Pérez Granda; Javier Hortal; José M Barrio; Emilia Cercenado; Patricia Muñoz
Journal:  Intensive Care Med       Date:  2013-06-28       Impact factor: 17.440

9.  Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset.

Authors:  J Vallés; A Pobo; O García-Esquirol; D Mariscal; J Real; R Fernández
Journal:  Intensive Care Med       Date:  2007-06-09       Impact factor: 17.440

10.  The paradox of ventilator-associated pneumonia prevention measures.

Authors:  Michael Klompas
Journal:  Crit Care       Date:  2009-10-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.